4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane...

Details 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane... 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane...

2006-02-21

2006-02-21

Coleman, Brenda (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S221000, C540S556000

Reexamination Certificate

active

07001902

ABSTRACT:
Compound corresponding to the general formula (I)in which R1, R2, R3, R4and R5each represent a hydrogen or halogen atom or a nitro, amino, trifluoromethyl, trifluoroalkoxy, cyano, hydroxyl, (C1–C6)alkyl or (C1–C6)alkoxy group and R6represents a (C1–C6)alkyl group.Therapeutic application.

REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 0307140 (1989-03-01), None
patent: WO 00/34279 (2000-06-01), None

Affiliated with

Also associated with

Rating

4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3687075